Functional assessment improves discrimination of clinical and biomarker-defined Alzheimers disease
In a contemporary and diverse cohort, most established Alzheimer's disease risk algorithms showed limited discriminatory power for clinical and biomarker outcomes, but including a functional assessment measure significantly improved their ability to distinguish between healthy cognition, mild cognitive impairment, and Alzheimer's disease.